Advisornet Financial’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-9
Closed -$146 – 2354
2023
Q4
$146 Buy
9
+5
+125% +$82 ﹤0.01% 2337
2023
Q3
$49 Hold
4
– – ﹤0.01% 2244
2023
Q2
$64 Buy
+4
New +$66 ﹤0.01% 2296
2020
Q3
– Sell
-150
Closed -$5K – 1825
2020
Q2
$5K Hold
150
– – ﹤0.01% 1454
2020
Q1
$4K Hold
150
– – ﹤0.01% 1478
2019
Q4
$4K Buy
+150
New +$3.57K ﹤0.01% 1593

Other funds holding NEO

Advisornet Financial's NEO Position: Q1 2024 in Review

Advisornet Financial sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 9 shares — an estimated $146 sold.

Advisornet Financial first reported a position in NEO in Q4 2019 and held it in 6 quarters. The position peaked at $5K in Q2 2020. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • Advisornet Financial reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • Advisornet Financial sold 9 NeoGenomics shares in Q1 2024, an estimated $146.
  • Advisornet Financial first reported a position in NeoGenomics in Q4 2019 and held it in 6 quarters.
  • Advisornet Financial's NeoGenomics position peaked at $5K in Q2 2020.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.